|
|
|
|
|
|
|
|
|
FOCUS ON TRANSLATIONAL RESEARCH
|
|
|
|
|
|
By Erin Harris, Editor-In-Chief, Cell & Gene
|
Kyverna's progress suggests that autoimmune CAR T's commercial viability will depend as much on manufacturing readiness and focused indication selection as on its potential to deliver durable, drug-free remission.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Receptor Occupancy In The Era Of Multispecific Therapeutics
|
|
Article | By Deborah Phippard, Ph.D., and Jenny Zilberberg, Precision for Medicine
|
Receptor occupancy studies face new challenges as multispecific therapeutics introduce complex target engagement, receptor trafficking, cellular interactions, and assay interpretation considerations.
|
|
|
|
|
|
|
|
|
|
Webinar: Viral Vector for Rare and Ultra-rare Disease
|
Rare and ultra-rare disease programs require viral vector strategies tailored to smaller patient populations. Explore practical approaches to right-size development and manufacturing, determine appropriate scale, reduce costs and timelines, and align processes with clinical and commercial needs. This webinar will share practical strategies for leveraging manufacturing partners and advancing toward proof of concept and clinical validation efficiently and cost-effectively. Click here to learn more.
|
|
|
|
TRANSLATIONAL RESEARCH SOLUTIONS
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
